Back
Evoke Pharma Vs. Belite Bio Industry Stock Comparison
Sell
17
EVOK
Evoke Pharma
Last Price:
4.43
Seasonality Move:
8.87%
Buy
89
BLTE
Belite Bio
Last Price:
67.60
Seasonality Move:
11.16%
Sell
17
Evoke Pharma (EVOK)
is a Sell
Is Evoke Pharma a Buy, Sell or Hold?
- The current Evoke Pharma [EVOK] share price is $4.37. The Score for EVOK is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- EVOK is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
89
Belite Bio (BLTE)
is a Buy
Is Belite Bio a Buy, Sell or Hold?
- The current Belite Bio [BLTE] share price is $67.44. The Score for BLTE is 89, which is 78% above its historic median score of 50, and infers lower risk than normal.
- BLTE is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
EVOK Stock Price Chart
What is Evoke Pharma's stock price today?
-
The Evoke Pharma share price today is $4.37
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EVOK is experiencing slight selling pressure.
BLTE Stock Price Chart
What is Belite Bio's stock price today?
-
The Belite Bio share price today is $67.44
The current trend is moderately bearish and BLTE is experiencing slight buying pressure.
EVOK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.28 | Sell |
Relative Strength Index (14 RSI): | 39.39 | Sell |
Chaikin Money Flow: | -1568 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.41 - 5.97) | Sell |
Bollinger Bands (100): | (4.39 - 6.01) | Sell |
BLTE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.5 | Buy |
Relative Strength Index (14 RSI): | 42.18 | Sell |
Chaikin Money Flow: | 27107 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (67.71 - 82.51) | Sell |
Bollinger Bands (100): | (44.39 - 68.09) | Buy |
EVOK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.45 | Sell |
20-day SMA: | 4.98 | Sell |
50-day SMA: | 5.13 | Sell |
200-day SMA: | 5.89 | Sell |
8-day EMA: | 4.48 | Sell |
20-day EMA: | 4.81 | Sell |
50-day EMA: | 5.04 | Sell |
200-day EMA: | 7.09 | Sell |
BLTE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 77.14 | Sell |
20-day SMA: | 77.31 | Sell |
50-day SMA: | 63.62 | Buy |
200-day SMA: | 50.02 | Buy |
8-day EMA: | 74.43 | Sell |
20-day EMA: | 74.55 | Sell |
50-day EMA: | 66.97 | Buy |
200-day EMA: | 52.46 | Buy |
Evoke Pharma Earnings Growth & EVOK Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $22.78 per share, and an increase next year of $4.46 per share.
Belite Bio Earnings Growth & BLTE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.18 per share.
Evoke Pharma Technical Analysis
Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Belite Bio Technical Analysis
Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |